Page 14 - Hal Barron News Today

The coronavirus pandemic is disrupting universities and research institutes across the world. But the same institutions are also working very hard to find out how the disease can be stopped and its effects mitigated. Follow this live blog for the latest updates on how the crisis is impacting research and innovation, and what governments, funders, companies, universities, associations and scientists are doing to stop or cope with the pandemic.

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

The coronavirus pandemic is disrupting universities and research institutes across the world. But the same institutions are also working very hard to find out how the disease can be stopped and its effects mitigated. Follow this live blog for the latest updates on how the crisis is impacting research and innovation, and what governments, funders, companies, universities, associations and scientists are doing to stop or cope with the pandemic.

British drugmaker GSK announced on Tuesday that its antibody-based Covid-19 therapy, developed in collaboration with Vir Biotechnology in the United States, is effective against all mutations of Omicron.

The coronavirus pandemic is disrupting universities and research institutes across the world. But the same institutions are also working very hard to find out how the disease can be stopped and its effects mitigated. Follow this live blog for the latest updates on how the crisis is impacting research and innovation, and what governments, funders, companies, universities, associations and scientists are doing to stop or cope with the pandemic.

The coronavirus pandemic is disrupting universities and research institutes across the world. But the same institutions are also working very hard to find out how the disease can be stopped and its effects mitigated. Follow this live blog for the latest updates on how the crisis is impacting research and innovation, and what governments, funders, companies, universities, associations and scientists are doing to stop or cope with the pandemic.

Sotrovimab is effective against all 37 identified mutations in the spike protein, GSK says

On Dec. 7, GlaxoSmithKline (Glaxo) and Vir Biotechnology announced an update to preclinical data concerning bioRxiv1, a preprint server, demonstrating that sotrovimab, an investigational monoclonal...

Despite having 37 new mutations in the viral spike protein, there does not appear to be any deaths associated with Omicron, although it’s spreading rapidly in South Africa.

London, December 7 Early signs indicate that the Omicron variant of Covid-19 is more transmissible than the Delta variant currently dominant in the UK, British Prime Minister Boris Johnson told his C